AFP17m
Vertex Announces FDA Approval of JOURNAVX™ (suzetrigine), a First-in-Class Treatment for Adults With Moderate-to-Severe Acute Pain
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
Five Charts on Market Signals Flashing Red Amid DeepSeek Selloff
LONDON (Reuters) - In a week when AI chipmaker Nvidia suffered the biggest one-day loss of value on record and the Federal Reserve said it was in no hurry to cut rates again, a few gauges underscore ...